US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 4.040
  • +0.040+1.00%
Close Mar 28 16:00 ET
  • 3.910
  • -0.130-3.22%
Post 18:49 ET
340.02MMarket Cap-2478P/E (TTM)

Atea Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.65%164.16M
16.73%46.57M
150.51%40.79M
9.10%35.24M
-1.44%41.57M
-38.66%130.65M
-43.80%39.9M
-70.38%16.28M
-37.54%32.3M
19.37%42.18M
Selling and administrative expenses
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
-4.72%11.38M
4.50%12.44M
43.19%12.54M
-General and administrative expense
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
-4.72%11.38M
4.50%12.44M
43.19%12.54M
Research and development costs
39.43%114.24M
27.25%35.05M
474.54%28.18M
11.10%22.06M
-2.29%28.95M
-51.00%81.94M
-52.36%27.54M
-88.60%4.91M
-50.11%19.86M
11.52%29.63M
Operating profit
-25.65%-164.16M
-16.73%-46.57M
-150.51%-40.79M
-9.10%-35.24M
1.44%-41.57M
-194.42%-130.65M
-132.93%-39.9M
26.49%-16.28M
-471.76%-32.3M
-237.58%-42.18M
Net non-operating interest income expense
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
8,167.92%4.38M
1,976.92%1.08M
68.97%98K
Non-operating interest income
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
8,167.92%4.38M
1,976.92%1.08M
68.97%98K
Other net income (expense)
Income before tax
-12.92%-134.94M
-13.14%-38.82M
-176.67%-32.92M
10.52%-27.93M
16.18%-35.27M
-186.22%-119.5M
-128.30%-34.31M
46.14%-11.9M
-457.19%-31.22M
-237.00%-42.08M
Income tax
128.36%1.02M
183.74%349K
105.77%221K
109.17%251K
197K
-120.63%-3.59M
-97.00%123K
-162.84%-3.83M
-98.33%120K
0
Net income
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
-237.00%-42.08M
Net income continuous Operations
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
-237.00%-42.08M
Minority interest income
Net income attributable to the parent company
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
-237.00%-42.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
-237.00%-42.08M
Basic earnings per share
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-195.21%-1.39
-129.08%-0.41
70.59%-0.1
-2,000.00%-0.38
-237.84%-0.51
Diluted earnings per share
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-201.46%-1.39
-130.60%-0.41
70.59%-0.1
-2,000.00%-0.38
-250.00%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.65%164.16M16.73%46.57M150.51%40.79M9.10%35.24M-1.44%41.57M-38.66%130.65M-43.80%39.9M-70.38%16.28M-37.54%32.3M19.37%42.18M
Selling and administrative expenses 2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M-4.72%11.38M4.50%12.44M43.19%12.54M
-General and administrative expense 2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M-4.72%11.38M4.50%12.44M43.19%12.54M
Research and development costs 39.43%114.24M27.25%35.05M474.54%28.18M11.10%22.06M-2.29%28.95M-51.00%81.94M-52.36%27.54M-88.60%4.91M-50.11%19.86M11.52%29.63M
Operating profit -25.65%-164.16M-16.73%-46.57M-150.51%-40.79M-9.10%-35.24M1.44%-41.57M-194.42%-130.65M-132.93%-39.9M26.49%-16.28M-471.76%-32.3M-237.58%-42.18M
Net non-operating interest income expense 162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M8,167.92%4.38M1,976.92%1.08M68.97%98K
Non-operating interest income 162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M8,167.92%4.38M1,976.92%1.08M68.97%98K
Other net income (expense)
Income before tax -12.92%-134.94M-13.14%-38.82M-176.67%-32.92M10.52%-27.93M16.18%-35.27M-186.22%-119.5M-128.30%-34.31M46.14%-11.9M-457.19%-31.22M-237.00%-42.08M
Income tax 128.36%1.02M183.74%349K105.77%221K109.17%251K197K-120.63%-3.59M-97.00%123K-162.84%-3.83M-98.33%120K0
Net income -17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M-237.00%-42.08M
Net income continuous Operations -17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M-237.00%-42.08M
Minority interest income
Net income attributable to the parent company -17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M-237.00%-42.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M-237.00%-42.08M
Basic earnings per share -17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-195.21%-1.39-129.08%-0.4170.59%-0.1-2,000.00%-0.38-237.84%-0.51
Diluted earnings per share -17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-201.46%-1.39-130.60%-0.4170.59%-0.1-2,000.00%-0.38-250.00%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg